Early Biomarkers of Tumor Response in High Dose Hypofractionated Radiotherapy Word Package 3 : Immune Response

ABSTRACT: This study will follow-up immune cell populations, secreted factors and released nanovesicles in the blood before, during and after high dose radiation therapy which should give new information of the efficacy of the hypofractionated high dose radiation therapy and a rationale for adjuvant immunotherapy.

DISEASE(S): Kidney Neoplasms,Melanoma,Colorectal Neoplasms,Carcinoma, Hepatocellular,Neoplasms

PROVIDER: 2189624 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR